Sunday, September 25, 2022
HomeNewsUS Health Authorities begins clinical trial to test monkeypox vaccine

US Health Authorities begins clinical trial to test monkeypox vaccine

US health authorities announced Thursday they would carry out a clinical trial to test different dosing strategies of the Jynneos monkeypox vaccine, amid uncertainty over its effectiveness.

The trial will enroll 200 adults aged 18-50 across the country and is sponsored by the National Institute of Allergy and Infectious Diseases.

The Jynneos vaccine, manufactured by Denmark-based Bavarian Nordic, has been approved by the United States for the prevention of smallpox and monkeypox in people aged 18 and older.

The new trial isn’t designed to produce an efficacy estimate, but rather measure the immune response of different dosing levels and administration methods.

LEAVE A REPLY

Please enter your comment!
Please enter your name here